Trial Profile
Postmarketing Study of ORTHO EVRA in Relation to Venous Thromboembolism, Ischemic Stroke, and Myocardial Infarction.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/norelgestromin (Primary) ; Ethinylestradiol/norgestimate
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 15 Jul 2016 Status changed from active, no longer recruiting to completed.
- 09 Jun 2010 New trial record